This country profile provides an overview of Mauritania’s progress in reaching those in need of mass NTD treatment based on 2016 data.

NTD mass treatment coverage index: 0/100
Overall rank: Joint 42nd

Treatment coverage

Lymphatic filariasis
N/A
Onchocerciasis
N/A
Schistosomiasis
0%
STH
N/A
Trachoma
0%
0 reported people received treatment in Mauritania in 2016 590,000 people in need did not receive treatment in Mauritania in 2016

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Mauritania.

Mauritania recommendations

These recommendations were given to heads of state at the African Union summit in January 2017 as part of the ALMA Scorecard for Accountability and Action.

  • Re-establish preventive chemotherapy for schistosomiasis and act on the awaited results of impact surveys for trachoma. Complete confirmatory mapping for lymphatic filariasis.
  • Increase budget allocation for neglected tropical diseases at the national level.
  • Provide timely data to the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) to enable monitoring and planning.

Lymphatic filariasis

Mauritania does not require mass treatment for lymphatic filariasis.

Onchocerciasis

Mauritania does not require mass treatment for onchocerciasis.

Schistosomiasis

⬇ Treatment coverage decreased from 30% in 2015 to 0% in 2016.

School-aged children needing treatment
412,800
School-aged children receiving treatment
0 reported

Soil-transmitted helminths

Mauritania does not require mass treatment for soil-transmitted helminths.

Trachoma

⬇ Treatment coverage decreased from 9% in 2015 to 0% in 2016.

People needing treatment
293,700
People receiving treatment
0 reported